Morgan Stanley Initiates Coverage On Inspire Medical Systems with Overweight Rating, Announces Price Target of $250
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley has initiated coverage on Inspire Medical Systems (NYSE:INSP) with an Overweight rating and set a price target of $250.
March 19, 2024 | 12:28 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Morgan Stanley initiated coverage on Inspire Medical Systems with an Overweight rating and a price target of $250.
The initiation of coverage by a major financial institution like Morgan Stanley with an Overweight rating suggests a positive outlook on the stock's future performance. The set price target of $250 indicates a significant upside potential from current levels, which could attract investor interest and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100